167 related articles for article (PubMed ID: 21435386)
1. Variability in commercial carbamazepine samples--impact on drug release.
Flicker F; Eberle VA; Betz G
Int J Pharm; 2011 May; 410(1-2):99-106. PubMed ID: 21435386
[TBL] [Abstract][Full Text] [Related]
2. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
Sehić S; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
Int J Pharm; 2010 Feb; 386(1-2):77-90. PubMed ID: 19900519
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T
Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541
[TBL] [Abstract][Full Text] [Related]
4. Recrystallization of commercial carbamazepine samples-a strategy to control dissolution variability.
Flicker F; Eberle VA; Betz G
Pharmaceutics; 2012 Jan; 4(1):58-70. PubMed ID: 24300180
[TBL] [Abstract][Full Text] [Related]
5. Increased dissolution rates of carbamazepine--gluconolactone binary blends processed by hot melt extrusion.
Moradiya HG; Nokhodchi A; Bradley MS; Farnish R; Douroumis D
Pharm Dev Technol; 2016; 21(4):445-52. PubMed ID: 25757644
[TBL] [Abstract][Full Text] [Related]
6. The effect of egg albumin on the crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets and in aqueous solutions.
Katzhendler I; Azoury R; Friedman M
J Control Release; 2000 Apr; 65(3):331-43. PubMed ID: 10699292
[TBL] [Abstract][Full Text] [Related]
7. Adsorption onto Mesoporous Silica Using Supercritical Fluid Technology Improves Dissolution Rate of Carbamazepine-a Poorly Soluble Compound.
Gandhi AV; Thipsay P; Kirthivasan B; Squillante E
AAPS PharmSciTech; 2017 Nov; 18(8):3140-3150. PubMed ID: 28534299
[TBL] [Abstract][Full Text] [Related]
8. Effect of crospovidone and hydroxypropyl cellulose on carbamazepine in high-dose tablet formulation.
Flicker F; Betz G
Drug Dev Ind Pharm; 2012 Jun; 38(6):697-705. PubMed ID: 22010838
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method.
Sethia S; Squillante E
J Pharm Sci; 2002 Sep; 91(9):1948-57. PubMed ID: 12210042
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
Rahman Z; Samy R; Sayeed VA; Khan MA
Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
Maghsoodi M; Tajalli Bakhsh AS
Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
[TBL] [Abstract][Full Text] [Related]
12. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):96-109. PubMed ID: 20674291
[TBL] [Abstract][Full Text] [Related]
13. Compatibility studies between carbamazepine and tablet excipients using thermal and non-thermal methods.
Joshi BV; Patil VB; Pokharkar VB
Drug Dev Ind Pharm; 2002 Jul; 28(6):687-94. PubMed ID: 12149961
[TBL] [Abstract][Full Text] [Related]
14. Effects of coformers on phase transformation and release profiles of carbamazepine cocrystals in hydroxypropyl methylcellulose based matrix tablets.
Qiu S; Li M
Int J Pharm; 2015 Feb; 479(1):118-28. PubMed ID: 25542989
[TBL] [Abstract][Full Text] [Related]
15. Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components.
Barakat NS; Elbagory IM; Almurshedi AS
Drug Deliv; 2009 Jan; 16(1):57-65. PubMed ID: 19555310
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the effect of hydroxypropyl methylcellulose on the phase transformation and release profiles of carbamazepine-nicotinamide cocrystal.
Li M; Qiu S; Lu Y; Wang K; Lai X; Rehan M
Pharm Res; 2014 Sep; 31(9):2312-25. PubMed ID: 24590881
[TBL] [Abstract][Full Text] [Related]
17. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
[TBL] [Abstract][Full Text] [Related]
18. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
19. Effect of different excipients on the physical characteristics of granules and tablets with carbamazepine prepared with polyethylene glycol 6000 by fluidized hot-melt granulation (FHMG).
Kraciuk R; Sznitowska M
AAPS PharmSciTech; 2011 Dec; 12(4):1241-7. PubMed ID: 21948307
[TBL] [Abstract][Full Text] [Related]
20. Carbamazepine/betaCD/HPMC solid dispersions. II. Physical characterization.
Koester LS; Mayorga P; Pereira VP; Petzhold CL; Bassani VL
Drug Dev Ind Pharm; 2003 Feb; 29(2):145-54. PubMed ID: 12648011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
